Intra-patient spatial comparison of non-metastatic and metastatic lymph nodes reveals the reduction of CD169+ macrophages by metastatic breast cancers

JSPS KAKENHI (16H06279, 20H03451, 20H04842, 22H04925, 19K16770, and 21K15530, 24K02236), JSPS Fellows (JP22KJ1822), AMED (JP21ck0106698), JST FOREST (JPMJFR2062), Caravel, Co., Ltd, Japan Foundation for Applied Enzymology, and Sumitomo Pharma Co., Ltd. under SKIPS.

Authors

Institutions

Publication Details

Journal
EBioMedicine
Published
2024-08-23
DOI
https://doi.org/10.1016/j.ebiom.2024.105271
Citations
6
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
1.70

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Intra-patient spatial comparison of non-metastatic and metastatic lymph nodes reveals the reduction of CD169+ macrophages by metastatic breast cancers

Shinpei Kawaoka, Tatsuki R. Kataoka, Masahiro Kawashima, Hironori Haga et al.
6 citations
EBioMedicine
Cancer Immunotherapy and Biomarkers
1.70
article

Intra-patient spatial comparison of non-metastatic and metastatic lymph nodes reveals the reduction of CD169+ macrophages by metastatic breast cancers

Shinpei Kawaoka, Tatsuki R. Kataoka, Masahiro Kawashima, Hironori Haga, Kosuke Kawaguchi, Yurina Maeshima, Masahiro Takada, Yasuhide Takeuchi, Yutaka Suzuki, Yukiko Fukui, Masahiro Hirata, Alexis Vandenbon, Masakazu Toi, Yumiko Ibi, Satoshi Morita
article en
6 citations

Abstract

JSPS KAKENHI (16H06279, 20H03451, 20H04842, 22H04925, 19K16770, and 21K15530, 24K02236), JSPS Fellows (JP22KJ1822), AMED (JP21ck0106698), JST FOREST (JPMJFR2062), Caravel, Co., Ltd, Japan Foundation for Applied Enzymology, and Sumitomo Pharma Co., Ltd. under SKIPS.

EBioMedicineVol. 107
Iwate Medical University (JP), Tohoku University (JP), Kyoto University (JP), Tokyo Metropolitan Komagome Hospital (JP), Kyoto University Hospital (JP), The University of Tokyo (JP)
Japan Foundation for Applied Enzymology, Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science
Good health and well-being
Openalex Percentile: Top 13%
Cancer Immunotherapy and Biomarkers
1.70
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.